These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 513481)

  • 1. Changes of hemodynamics and glomerular ultrafiltration in renal hypertension of rats.
    Schwietzer G; Gertz KH
    Kidney Int; 1979 Feb; 15(2):134-43. PubMed ID: 513481
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiologic studies with saralasin in animals.
    Gavras H; Gavras I; Brunner HR; Liang CS
    Kidney Int Suppl; 1979 Mar; (9):S20-8. PubMed ID: 384069
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of saralasin infusion on bilateral renal function in two-kidney, one-clip Goldblatt hypertensive rats.
    Huang WC; Ploth DW; Navar LG
    Clin Sci (Lond); 1982 Jun; 62(6):573-9. PubMed ID: 7083749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic effects of sar1-ala8-angiotensin in patients with renovascular hypertension (author's transl)].
    Philipp T; Zschierdrich H; Distler A
    Klin Wochenschr; 1977 Sep; 55(18):917-9. PubMed ID: 916618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular hemodynamics in rats with chronic sodium depletion. Effect of saralasin.
    Steiner RW; Tucker BJ; Blantz RC
    J Clin Invest; 1979 Aug; 64(2):503-12. PubMed ID: 457865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
    Beyer J; Liebau G; Steiner B; Schick K; Hayduk K
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577
    [No Abstract]   [Full Text] [Related]  

  • 7. Saralasin (1-sar-8-ala-angiotensin II): pharmacology and clinical use in angiotensin-dependent hypertension.
    Streeten DH; Castellian AW; Micalizzi ER; Dalakos TG; Anderson GH; Freiberg JM; Keenan RE
    Contrib Nephrol; 1976; 3():52-70. PubMed ID: 1026370
    [No Abstract]   [Full Text] [Related]  

  • 8. [SAR1, ALA8]-Angiotensin II (saralasin): a symposium. Introduction.
    Vaughan ED; Peach MJ
    Kidney Int Suppl; 1979 Mar; (9):S1-2. PubMed ID: 289858
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension.
    Ichikawa I; Ferrone RA; Duchin KL; Manning M; Dzau VJ; Brenner BM
    Circ Res; 1983 Nov; 53(5):592-602. PubMed ID: 6194914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of administration of Sar1-Ala8-angiotensin II during the development and maintenance of renal hypertension in the rat.
    Fernandes M; Fiorentini R; Onesti G; Bellini G; Gould AB; Hessan H; Kim KE; Swartz C
    Clin Sci Mol Med; 1978 Jun; 54(6):633-7. PubMed ID: 657733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saralasin in human hypertension: the early experience.
    Brunner HR; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S36-43. PubMed ID: 289862
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of an angiotensin blocker (saralasin) on kidney function in dehydrated sheep.
    Yesberg NE; Henderson M; Wilson K; Law S; Cross RB
    Q J Exp Physiol; 1982 Jan; 67(1):97-103. PubMed ID: 7079453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal and tubuloglomerular feedback effects of [Sar1,Ala8]angiotensin II in the rat.
    Ploth DW; Roy RN
    Am J Physiol; 1982 Feb; 242(2):F149-57. PubMed ID: 7039342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of an angiotensin II antagonist in rabbits with perinephritis hypertension.
    Ichikawa S; Johnson JA; Stanton MW; Payne CG; Keitzer WF
    Proc Soc Exp Biol Med; 1977 Jun; 155(2):259-63. PubMed ID: 866354
    [No Abstract]   [Full Text] [Related]  

  • 15. Single-nephron hemodynamics in one-kidney one-clip hypertension in the rat.
    Schweitzer G; Gertz KH
    Ren Physiol; 1984; 7(1):46-53. PubMed ID: 6701395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension.
    Fagard R; Amery A; Ljnen P; Reybrouck T; Billiet L
    Prog Biochem Pharmacol; 1976; 12():242-9. PubMed ID: 1019167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sodium depletion and angiotensin II antagonism in renal hypertensive rabbits.
    Johnson JA; Stubbs DH; Stanton M; Payne C; Ichikawa S; Keitzer WF
    Am J Physiol; 1977 Oct; 233(4):H514-9. PubMed ID: 910968
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic correlates of saralasin: responsiveness in hypertension.
    Kem DC; Frohlich ED; de Carvalho JG; Dunn FG; Chrysant SG; Danisa K; Wambach G
    Kidney Int Suppl; 1979 Mar; (9):S68-74. PubMed ID: 289866
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 1-Sar-8-Ala-angiotensin II on systemic and pulmonary haemodynamics in hypertensive patients.
    Fagard R; Amery A; Lijnen P; Reybrouck T; Joossens JV; Billiet L; Moerman E; De Schaepdryver A
    Clin Exp Pharmacol Physiol; 1978; 5(5):457-64. PubMed ID: 729204
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK; Williams GH
    Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.